Related Experiment Video
Updated: Apr 23, 2026
09:40
Ultrasound Assessment of Flow-Mediated Dilation of the Brachial and Superficial Femoral Arteries in Rats
Published on: November 3, 2016
11.1K
Renal fibromuscular dysplasia
Albeir Y Mousa1, Gurpreet Gill1
1Department of Surgery, R. C. Byrd Health Sciences Center, West Virginia University, 3110 MacCorkle Avenue SE, Charleston, WV 25304.
Seminars in Vascular Surgery
|September 16, 2014
Summary
Renal artery fibromuscular dysplasia (FMD) is a genetic vascular disease causing young-onset hypertension. Diagnosis and minimally invasive treatments are improving patient outcomes.
Area of Science:
- Vascular Medicine
- Genetics
- Nephrology
Background:
- Renal artery fibromuscular dysplasia (FMD) is a nonatherosclerotic, noninflammatory vasculopathy affecting renal arteries.
- The exact etiology of FMD remains unknown, but genetic factors are strongly implicated in its pathogenesis.
- A key clinical presentation is sudden-onset, treatment-resistant hypertension in young individuals.
Purpose of the Study:
- To provide clinicians with an updated understanding of diagnosing renal artery fibromuscular dysplasia.
- To review current evidence on the treatment options for renal artery fibromuscular dysplasia.
- To highlight the impact of minimally invasive interventions on managing this condition.
Main Methods:
- Review of diagnostic tools for identifying renal artery fibromuscular dysplasia.
- Evaluation of evidence supporting various treatment strategies, including minimally invasive interventions.
- Synthesis of current clinical knowledge on the presentation and management of FMD.
Main Results:
- Several diagnostic modalities are available for accurate diagnosis of renal artery fibromuscular dysplasia.
- Minimally invasive interventions have significantly advanced treatment options for FMD.
- Early diagnosis and appropriate management are crucial for patients with renal artery fibromuscular dysplasia.
Conclusions:
- Renal artery fibromuscular dysplasia requires a comprehensive diagnostic approach.
- Minimally invasive treatments offer effective therapeutic options for renal artery fibromuscular dysplasia.
- Further research into the etiology of FMD is warranted.
Related Concept Videos
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
930
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930
01:23Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
01:25Cardiomyopathy I: Introduction and Classification
809
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
809
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
793
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
01:22Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
01:21Smooth Endoplasmic Reticulum
6.5K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
6.5K